Hiroji Uemura

Papers

Total Citations

H-Index

About

Hiroji Uemura is a leading urologic oncologist whose research centers on geriatric oncology and prostate cancer management, particularly in elderly populations. His major contributions include pioneering the use of the Geriatric 8 (G8) screening tool to assess frailty in prostate cancer patients, demonstrating its prognostic value for advanced disease outcomes. This work, highlighted in his 2020 paper (9 citations), addresses the critical need for tailored geriatric assessments in Japan’s aging population, where prostate cancer is the most common malignancy. Uemura’s research bridges the gap between oncology and geriatrics, emphasizing that frailty screening can guide treatment decisions and improve survival predictions. His studies have shaped clinical guidelines for elderly cancer care, earning recognition for integrating comprehensive geriatric evaluations into standard urologic practice. With a career dedicated to optimizing outcomes for older patients, Uemura’s impact extends beyond citation counts to influencing how clinicians approach frailty in oncologic settings. His work remains foundational for researchers exploring personalized, age-adapted therapies in prostate cancer.